TYRA   $24.385  1.60% Market Closed After Close 24.3595 -0.10%

Tyra Biosciences Inc
Total Cash 373.80M
totalCashPerShare 7.088
EBITDA -95.02M
Total Debt 6.40M
quickRatio 36.187
currentRatio 36.464
Total Revenue
debtToEquity 1.702
Revenue/Share
ROA -0.18571
ROE -0.26501
grossProfits
freeCashflow -35.14M
operatingCashflow -62.96M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 752.73M
forwardPE -10.610526
floatShares 16.20M
sharesOutstanding 52.81M
sharesShort 2.26M
sharesShortPriorMonth 2.22M
dateShortInterest
sharesPercentSharesOut 0.04%
heldPercentInsiders 0.05%
heldPercentInstitutions 0.99%
Short Ratio help_outline 13.12%
shortPercentOfFloat 0.08%
impliedSharesOutstanding
bookValue 7.131
Price To Book help_outline 2.83
earningsQuarterlyGrowth
netIncomeToCommon -81.44M
trailingEps -1.70%
forwardEps -1.90%
enterpriseToEbitda -7.92
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.4 3Q 2024
institutionsCount 123
lastUpdated Sept. 16, 2024, 8:34 p.m.